Geron Corp
NASDAQ:GERN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Geron Corp
NASDAQ:GERN
|
US |
|
Blackline Inc
NASDAQ:BL
|
US |
|
G
|
Goodbridge Capital Corp
XTSX:IDEX
|
CA |
|
M
|
Mitek Systems Inc
F:MKQ
|
US |
|
C
|
Ceragon Networks Ltd
SWB:GGN
|
IL |
|
A
|
Actic Group AB
STO:ATIC
|
SE |
|
Aditya Birla Lifestyle Brands Ltd
NSE:ABLBL
|
IN |
|
Red River Bancshares Inc
F:7RR
|
US |
|
Noevir Holdings Co Ltd
TSE:4928
|
JP |
|
Corbus Pharmaceuticals Holdings Inc
F:3371
|
US |
|
Futu Holdings Ltd
LSE:0FUT
|
HK |
|
R
|
RR Donnelley & Sons Co
F:DLLN
|
US |
|
Takeda Pharmaceutical Co Ltd
F:TKD
|
JP |
Wall St Price Targets
GERN Price Targets Summary
Geron Corp
According to Wall Street analysts, the average 1-year price target for
GERN is 3.47 USD with a low forecast of 1.01 USD and a high forecast of 5.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GERN's stock price target?
Price Target
3.47
USD
According to Wall Street analysts, the average 1-year price target for
GERN is 3.47 USD with a low forecast of 1.01 USD and a high forecast of 5.25 USD.
What is the Revenue forecast for Geron Corp?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 38%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Geron Corp?
Projected CAGR
20%
The compound annual growth rate for Gross Profit over the next 8 years is 20%.